Alzheimer's Disease
Alzheimer's disease is a progressive neurological disorder that leads to memory loss, confusion, and changes in behavior, significantly impacting daily life.
Alzheimer’s Disease: MTX46943 Study
We are investigating a new compound to see if it is safe and effective for treating Alzheimer’s disease and other neurological disorders. This study looks at how the drug is absorbed and processed in the body.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Pharmaceutical Research Associates Group B.V.
Program Management
Groningen, Netherlands
Sponsor: Muna Therapeutics ApS
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.